1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Annick Desjardins, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab Human CMV pp65-LAMP mRNA-pulsed autologous DCs, Temozolomide, Varlilumab - Glioblastoma | Phase 2 | Active not recruiting | Annick Desjardins, MD | 43 | 2020-08-26 | 2026-05-22 |
Glioblastoma (1)
Temozolomide (1) · Toxoids (1) · varlilumab (1)
United States (1)